Actelion
Pharmaceutical company
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.
Actelion focuses on the manufacture of drugs that treat rare and orphan diseases. Wikipedia
Headquarters: Allschwil, Switzerland
Founded: 1997
Purchase price: $30 billion
Founders: Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann
Parent organizations: Johnson & Johnson and Johnson & Johnson Management ltd